Related Experiment Video
Updated: Aug 25, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Machine Learning Model to Predict Diagnosis of Mild Cognitive Impairment by Using Radiomic and Amyloid Brain PET
Andrea Ciarmiello1, Elisabetta Giovannini1, Sara Pastorino1
1From the Nuclear Medicine Unit.
A new deep learning model accurately predicts amnestic mild cognitive impairment (aMCI) using radiomic features and amyloid PET scans. This approach shows improved diagnostic performance compared to standard SUV measurements alone.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Biomarkers
Background:
- Mild cognitive impairment (MCI) is a precursor to Alzheimer's disease.
- Early and accurate diagnosis of MCI is crucial for timely intervention.
- Current diagnostic methods have limitations in sensitivity and specificity.
Purpose of the Study:
- To develop a deep learning model for predicting amnestic MCI (aMCI) diagnosis.
- To utilize radiomic features and amyloid positron emission tomography (PET) data.
- To compare the model's performance against standard SUV measurements.
Main Methods:
- A cohort of 328 subjects (normal controls and aMCI) from ADNI and a clinical trial were analyzed.
- Radiomic features and amyloid loads were extracted from brain PET scans.
- A feed-forward neural network was trained and validated using selected features.
Main Results:
- The deep learning model achieved an Area Under the Curve (AUC) of 90% for aMCI prediction.
- The model demonstrated 80% accuracy and 78% F1-score on the test set.
- This outperformed SUV performance, which had an AUC of 71%.
Conclusions:
- The developed machine learning model accurately identifies MCI subjects with 84% specificity and 81% sensitivity.
- Deep learning algorithms integrating radiomic data and amyloid PET load enhance MCI diagnosis prediction.
- This approach offers a significant improvement over using SUV alone for MCI diagnosis.
More Related Videos
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
08:40Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021